PAR paradigm biopharmaceuticals limited..

Why Zilosul could be a golden goose!!, page-77

  1. 1,001 Posts.
    lightbulb Created with Sketch. 134
    All players need an ace up there sleeve in this case that ace may well be getting Australian provisional pathway approval to hopefully sell to the Australian market in 2025.From a funding perspective and return on investment this strategy makes a lot of sense to future proof stage 3 trials including dmoad. Putting a lot of faith in the board being able to negotiate a deal around this scenario.
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
29.0¢
Change
-0.005(1.69%)
Mkt cap ! $112.9M
Open High Low Value Volume
29.5¢ 31.0¢ 28.5¢ $431.5K 1.469M

Buyers (Bids)

No. Vol. Price($)
3 21578 28.5¢
 

Sellers (Offers)

Price($) Vol. No.
30.5¢ 9000 1
View Market Depth
Last trade - 16.10pm 13/06/2025 (20 minute delay) ?
PAR (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.